Tapewire

Nasdaq · USD

BIVI

BIOVIE INC.

Export transactions ↓
Tapewire entity
7702
SEC CIK
0001580149
Parsed reports
145

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202640
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 31, 2021 Filed Jan 25, 2022 17:31 UTC
DO CUONG VDirector · President & CEO
GrantCommon Stock 21,710 $0.00 $0.00
Disclosure

SEC source: 0001520138-22-000029 · ownership.xml · nonDerivative · entry 1

DO CUONG V · CIK 0001477037 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,759

Read SEC document
December 07, 2021 Filed Dec 9, 2021 21:46 UTC PurchaseClass A common stock, par value $0.0001 2,000 $5.40 $10,798.00
Disclosure

SEC source: 0001520138-21-000777 · ownership.xml · nonDerivative · entry 1

KIM JOANNE WENDY · CIK 0001771317 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
August 20, 2021 Filed Sep 16, 2021 18:38 UTC
DO CUONG VDirector · CEO & President
GrantStock Option (right to buy) · Derivative 745,000 $0.00 Strike: $7.74 $0.00
Disclosure

SEC source: 0001520138-21-000556 · ownership.xml · derivative · entry 1

Do Cuong V · CIK 0001477037 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 745,000

Underlying: COMMON STOCK · 745,000 shares

Expires 2031-08-19

F2 · derivative.exercise_date: This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.

F1 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC.

Read SEC document
August 20, 2021 Filed Sep 16, 2021 16:52 UTC
MARKHAM PENELOPEEVP Liver Cirrhosis R&D
GrantStock Option (right to buy) · Derivative 124,167 $0.00 Strike: $7.74 $0.00
Disclosure

SEC source: 0001520138-21-000552 · ownership.xml · derivative · entry 1

MARKHAM PENELOPE · CIK 0001770555 · EVP Liver Cirrhosis R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,167

Underlying: Common Stock · 124,167 shares

Expires 2031-08-19

F1 · derivative.exercise_date: This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.

Read SEC document
August 20, 2021 Filed Sep 16, 2021 16:50 UTC
Adams Jonathan MEVP Liver Cirrhosis Programs
GrantStock Option (right to buy) · Derivative 124,167 $0.00 Strike: $7.74 $0.00
Disclosure

SEC source: 0001520138-21-000550 · ownership.xml · derivative · entry 1

Adams Jonathan M · CIK 0001749582 · EVP Liver Cirrhosis Programs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,167

Underlying: COMMON STOCK · 124,167 shares

Expires 2031-08-19

F1 · derivative.exercise_date: This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.

Read SEC document
August 20, 2021 Filed Sep 16, 2021 16:47 UTC
KIM JOANNE WENDYChief Financial Officer
GrantStock Option (right to buy) · Derivative 124,167 $0.00 Strike: $7.74 $0.00
Disclosure

SEC source: 0001520138-21-000548 · ownership.xml · derivative · entry 1

KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,167

Underlying: COMMON STOCK · 124,167 shares

Expires 2031-08-19

F1 · derivative.exercise_date: This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.

Read SEC document
August 20, 2021 Filed Sep 28, 2021 18:13 UTC
Ahlem Clarence N.EVP Neuroscience Product Dev.
GrantStock Option (right to buy) · Derivative 124,167 $0.00 Strike: $7.74 $0.00
Disclosure

SEC source: 0001520138-21-000588 · ownership.xml · derivative · entry 1

Ahlem Clarence N. · CIK 0001884599 · EVP Neuroscience Product Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,167

Underlying: COMMON STOCK · 124,167 shares

Expires 2031-08-19

F1 · derivative.exercise_date: This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.

Read SEC document
August 20, 2021 Filed Oct 8, 2021 14:59 UTC
READING CHRISTOPHEREVP Neuroscience R&D
GrantStock Option (right to buy) · Derivative 124,167 $0.00 Strike: $7.74 $0.00
Disclosure

SEC source: 0001520138-21-000612 · ownership.xml · derivative · entry 1

READING CHRISTOPHER · CIK 0001239658 · EVP Neuroscience R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,167

Underlying: Common Stock · 124,167 shares

Expires 2031-08-19

F1 · derivative.exercise_date: This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.

Read SEC document
June 16, 2021 Filed Oct 29, 2021 21:09 UTC
Adams Jonathan MEVP Liver Cirrhosis Programs
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001520138-21-000689 · ownership.xml · nonDerivative · entry 1

Adams Jonathan M · CIK 0001749582 · EVP Liver Cirrhosis Programs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,630

Read SEC document
June 10, 2021 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
GrantCommon Stock 8,361,308 Not disclosed Not disclosed
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · nonDerivative · entry 9

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 19,529,846

F9 · price: The Issuer issued these shares to NeurMedix, Inc. ("NeurMedix") in partial consideration for the acquisition of certain assets from NeurMedix and the assumption of certain liabilities of NeurMedix pursuant to the Asset Purchase Agreement, dated April 27, 2021, by and among the Issuer, NeurMedix, Inc. and Acuitas. In connection with the closing, NeurMedix assigned the rights to receive such shares to Acuitas.

F3 · ownership.nature: Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Read SEC document
December 18, 2020 Filed Mar 4, 2021 20:00 UTC Grantoptions · Derivative 97,300 $13.91 Strike: $13.91 $1,353,443.00
Disclosure

SEC source: 0001168218-21-000001 · primary_doc.xml · derivative · entry 1

ROGICH SIGMUND · CIK 0001168218 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,300

Underlying: common stock · 97,300 shares

Expires 2023-12-18

F1 · security: non-qualified options issued from company 2019 Omnibus Equity Incentive Plan, subject to continuation of service to company

F2 · derivative.exercise_date: 25% vest on grant date; remaining 75% vest over 3-year period on 1st, 2nd, 3rd anniversary of grant date

Read SEC document
December 18, 2020 Filed Mar 4, 2021 20:15 UTC Grantoptions · Derivative 103,100 $13.91 Strike: $13.91 $1,434,121.00
Disclosure

SEC source: 0001730468-21-000002 · primary_doc.xml · derivative · entry 1

Sherman Michael Edward · CIK 0001730468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,906

Underlying: common stock · 103,100 shares

Expires 2023-12-18

F1 · security: non-qualified options issued from company 2019 Omnibus Equity Incentive Plan, subject to continuation of service to company

F2 · derivative.exercise_date: 25% vest on grant date; remaining 75% vest over 3-year period on 1st, 2nd, 3rd anniversary of grant date

Read SEC document
December 18, 2020 Filed Mar 5, 2021 00:02 UTC
DO CUONG VDirector
Grantoptions · Derivative 97,500 $13.91 Strike: $13.91 $1,356,225.00
Disclosure

SEC source: 0001477037-21-000002 · primary_doc.xml · derivative · entry 1

Do Cuong V · CIK 0001477037 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares are held in the name of Do & Rickles Investments LLC

Disclosed balance after: 171,366

Underlying: common stock · 97,500 shares

Expires 2023-12-18

F1 · security: non-qualified options issued from company 2019 Omnibus Equity Incentive Plan, subject to continuation of service to company

F2 · derivative.exercise_date: 25% vest on grant date; remaining 75% vest over 3-year period on 1st, 2nd, 3rd anniversary of grant date

Read SEC document
December 18, 2020 Filed Mar 5, 2021 00:47 UTC Grantoptions · Derivative 99,000 $13.91 Strike: $13.91 $1,377,090.00
Disclosure

SEC source: 0001703090-21-000002 · primary_doc.xml · derivative · entry 1

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,988

Underlying: common stock · 99,000 shares

Expires 2023-12-18

F1 · security: non-qualified options issued from company 2019 Omnibus Equity Incentive Plan, subject to continuation of service to company

F2 · derivative.exercise_date: 25% vest on grant date; remaining 75% vest over 3-year period on 1st, 2nd, 3rd anniversary of grant date

Read SEC document
December 18, 2020 Filed Mar 5, 2021 14:42 UTC
GORLIN STEVEDirector
Grantoptions · Derivative 96,300 $13.91 Strike: $13.91 $1,339,533.00
Disclosure

SEC source: 0001730468-21-000003 · primary_doc.xml · derivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,300

Underlying: common stock · 96,300 shares

Expires 2023-12-18

F1 · security: non-qualified options issued from company 2019 Omnibus Equity Incentive Plan, subject to continuation of service to company

F2 · derivative.exercise_date: 25% vest on grant date; remaining 75% vest over 3-year period on 1st, 2nd, 3rd anniversary of grant date

Read SEC document
December 18, 2020 Filed Sep 28, 2021 20:25 UTC GrantStock Option (right to buy) · Derivative 95,900 $0.00 Strike: $13.91 $0.00
Disclosure

SEC source: 0001520138-21-000583 · ownership.xml · derivative · entry 1

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,900

Underlying: Common Stock · 95,900 shares

Expires 2025-12-18

F1 · derivative.exercise_date: This option was 25% vested upon grant, with an additional 25% on each of the first three anniversaries of the grant.

Read SEC document
December 18, 2020 Filed Sep 29, 2021 10:56 UTC GrantStock Option (right to buy) · Derivative 102,500 $0.00 Strike: $13.91 $0.00
Disclosure

SEC source: 0001520138-21-000592 · ownership.xml · derivative · entry 3

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,500

Underlying: Common Stock · 102,500 shares

Expires 2025-12-18

F1 · derivative.exercise_date: This option was 25% vested upon grant, with an additional 25% on each of the first three anniversaries of the grant.

Read SEC document
November 03, 2020 Filed Dec 15, 2020 15:01 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 2,430 $7.95 $19,318.50
Disclosure

SEC source: 0001520138-20-000616 · ownership.xml · nonDerivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,100

Read SEC document
October 30, 2020 Filed Dec 15, 2020 15:00 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 2,570 $7.97 $20,482.90
Disclosure

SEC source: 0001520138-20-000614 · ownership.xml · nonDerivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,670

Read SEC document
October 21, 2020 Filed Oct 22, 2020 15:10 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 5,000 $9.19 $45,950.00
Disclosure

SEC source: 0001520138-20-000504 · ownership.xml · nonDerivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,100

Read SEC document
October 15, 2020 Filed Oct 19, 2020 14:59 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 100 $10.27 $1,027.00
Disclosure

SEC source: 0001520138-20-000492 · ownership.xml · nonDerivative · entry 5

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 20,100

Read SEC document
October 15, 2020 Filed Oct 19, 2020 14:59 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 1,000 $10.18 $10,180.00
Disclosure

SEC source: 0001520138-20-000492 · ownership.xml · nonDerivative · entry 4

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 21,100

Read SEC document
October 15, 2020 Filed Oct 19, 2020 14:59 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 4,000 $10.19 $40,760.00
Disclosure

SEC source: 0001520138-20-000492 · ownership.xml · nonDerivative · entry 3

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 25,100

Read SEC document
October 15, 2020 Filed Oct 19, 2020 14:59 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 5,000 $10.10 $50,500.00
Disclosure

SEC source: 0001520138-20-000492 · ownership.xml · nonDerivative · entry 2

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,100

Read SEC document
October 15, 2020 Filed Oct 19, 2020 14:59 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 5,000 $10.01 $50,050.00
Disclosure

SEC source: 0001520138-20-000492 · ownership.xml · nonDerivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,100

Read SEC document
October 13, 2020 Filed Oct 21, 2020 20:43 UTC Grantoptions · Derivative 800 $9.90 Strike: $9.90 $7,920.00
Disclosure

SEC source: 0001771317-20-000007 · primary_doc.xml · derivative · entry 1

Sherman Michael Edward · CIK 0001730468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,806

Underlying: common stock · 800 shares

Expires 2025-10-13

Read SEC document
October 09, 2020 Filed Oct 14, 2020 14:07 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 282 $9.61 $2,710.02
Disclosure

SEC source: 0001520138-20-000484 · ownership.xml · nonDerivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
October 07, 2020 Filed Oct 14, 2020 14:05 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 4,718 $9.42 $44,443.56
Disclosure

SEC source: 0001520138-20-000482 · ownership.xml · nonDerivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,718

Read SEC document
October 01, 2020 Filed Oct 22, 2020 00:35 UTC
KIM JOANNE WENDYChief Financial Officer
Grantoptions · Derivative 800 $9.54 Strike: $9.54 $7,632.00
Disclosure

SEC source: 0001771317-20-000006 · primary_doc.xml · derivative · entry 1

KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,400

Underlying: common stock · 800 shares

Expires 2025-10-01

Read SEC document
September 22, 2020 Filed Oct 14, 2020 13:49 UTC
GORLIN STEVEDirector
PurchaseClass A common stock, par value $0.0001 15,000 $10.00 $150,000.00
Disclosure

SEC source: 0001520138-20-000480 · ownership.xml · nonDerivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
September 22, 2020 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
Exercise / conversionWarrants (right to buy) · Derivative 299,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · derivative · entry 19

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 299,750 shares

Expires 2025-07-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_price: Exercisable at the lower of $4 (adjusted to reflect the Reverse Stock Split) or 80% of the offering price to the public in the Uplisting Offering.

F8 · price: See Exhibit 99.1

F3 · ownership.nature: Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Read SEC document
September 22, 2020 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
Exercise / conversionWarrants (right to buy) · Derivative 1,250,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · derivative · entry 18

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,250,000 shares

Expires 2024-09-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_price: Exercisable at the lower of $4 (adjusted to reflect the Reverse Stock Split) or 80% of the offering price to the public in the Uplisting Offering.

F2 · shares: Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the "Reverse Stock Split").

F8 · price: See Exhibit 99.1

F2 · derivative.underlying_shares: Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the "Reverse Stock Split").

F3 · ownership.nature: Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Read SEC document
September 22, 2020 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
Disposition to issuer10% Convertible Debenture due 2020 · Derivative Not disclosed $0.00 $2,000,000.00
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · derivative · entry 17

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires 2020-09-24

F12 · derivative.exercise_price: On September 22, 2020, the Issuer paid approximately $1.8 million to Acuitas satisfy all amounts owed on the Debenture due September 24, 2020.

F12 · kind: On September 22, 2020, the Issuer paid approximately $1.8 million to Acuitas satisfy all amounts owed on the Debenture due September 24, 2020.

F6 · reported_value: See Exhibit 99.1

F6 · derivative.underlying_shares: See Exhibit 99.1

F3 · ownership.nature: Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Read SEC document
September 22, 2020 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
Exercise / conversionCommon Stock 1,549,750 $0.00 $154.98
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · nonDerivative · entry 8

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 11,168,538

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · kind: See Exhibit 99.1

F3 · ownership.nature: Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Read SEC document
September 22, 2020 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
GrantCommon Stock 5,359,832 Not disclosed Not disclosed
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · nonDerivative · entry 7

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 9,618,788

F8 · kind: See Exhibit 99.1

F8 · price: See Exhibit 99.1

F3 · ownership.nature: Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Read SEC document
July 13, 2020 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
GrantWarrants (right to buy) · Derivative 299,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · derivative · entry 16

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 299,750

Underlying: Common Stock · 299,750 shares

Expires 2025-07-13

F6 · derivative.exercise_price: See Exhibit 99.1

F11 · derivative.exercise_price: Exercisable at the lower of $4 (adjusted to reflect the Reverse Stock Split) or 80% of the offering price to the public in the Uplisting Offering.

F6 · price: See Exhibit 99.1

F3 · ownership.nature: Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Read SEC document
June 16, 2020 Filed Oct 23, 2020 20:19 UTC
GORLIN STEVEDirector
Othernone 0 $0.00 $0.00
Disclosure

SEC source: 0001807148-20-000002 · primary_doc.xml · nonDerivative · entry 1

GORLIN STEVE · CIK 0001033742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: FORM 3 NOT PREVIOUSLY REPORTED; MR. GORLIN BECAME A DIRECTOR ONLY. NO SECURITIES WERE BENEFICIALLY HELD AT THIS TIME.

Read SEC document
June 16, 2020 Filed Nov 16, 2020 15:09 UTC Othernone 0 $0.00 $0.00
Disclosure

SEC source: 0001168218-20-000002 · primary_doc.xml · nonDerivative · entry 1

ROGICH SIGMUND · CIK 0001168218 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: FORM 3 NOT PREVIOUSLY REPORTED; MR. ROGICH BECAME A DIRECTOR ONLY. NO SECURITIES WERE BENEFICIALLY HELD AT THIS TIME.

Read SEC document
January 19, 2020 Filed Oct 22, 2020 00:03 UTC
DO CUONG VDirector
Grantoptions · Derivative 800 $2.80 Strike: $2.80 $2,240.00
Disclosure

SEC source: 0001771317-20-000003 · primary_doc.xml · derivative · entry 3

Do Cuong V · CIK 0001477037 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 73,866

Underlying: common stock · 800 shares

Expires 2025-01-19

F3 · balance_after: On 11/21/2019 a reverse stock split was effected; derivative securities are post-split calculations.

F4 · ownership.nature: Shares are held in the name of Do & Rickes Investments LLC

Read SEC document
January 19, 2020 Filed Oct 21, 2020 23:40 UTC
Adams Jonathan MChief Operating Officer
Grantoptions · Derivative 800 $2.80 Strike: $2.80 $2,240.00
Disclosure

SEC source: 0001771317-20-000002 · primary_doc.xml · derivative · entry 1

Adams Jonathan M · CIK 0001749582 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,364

Underlying: common stock · 800 shares

Expires 2025-01-19

F1 · balance_after: On 11/21/2019 a reverse stock split was effected; derivative securities are post-split calculations.

Read SEC document
January 19, 2020 Filed Oct 22, 2020 00:18 UTC Grantoptions · Derivative 800 $2.80 Strike: $2.80 $2,240.00
Disclosure

SEC source: 0001771317-20-000004 · primary_doc.xml · derivative · entry 3

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,988

Underlying: common stock · 800 shares

Expires 2025-01-19

F2 · balance_after: On 11/21/2019 a reverse stock split was effected; derivative securities are post-split calculations.

Read SEC document
January 19, 2020 Filed Oct 21, 2020 22:11 UTC
MARKHAM PENELOPEChief Science Officer
Grantoptions · Derivative 800 $2.80 Strike: $2.80 $2,240.00
Disclosure

SEC source: 0001770555-20-000001 · primary_doc.xml · derivative · entry 1

MARKHAM PENELOPE · CIK 0001770555 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,200

Underlying: common stock · 800 shares

Expires 2025-01-19

F1 · balance_after: On 11/21/2019 a reverse stock split was effected; derivative securities are post-split calculations.

Read SEC document
January 19, 2020 Filed Sep 29, 2021 10:56 UTC GrantStock Option (right to buy) · Derivative 800 $0.00 Strike: $2.80 $0.00
Disclosure

SEC source: 0001520138-21-000592 · ownership.xml · derivative · entry 2

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800

Underlying: Common Stock · 800 shares

Expires 2025-01-19

Read SEC document
January 02, 2020 Filed Oct 21, 2020 20:26 UTC GrantCommon Stock 1,600 $3.50 $5,600.00
Disclosure

SEC source: 0001771317-20-000005 · primary_doc.xml · nonDerivative · entry 1

Sherman Michael Edward · CIK 0001730468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,679

F1 · balance_after: On 11/21/2019 a reverse stock split was effected; total shares indicated are post-split.

Read SEC document
January 02, 2020 Filed Oct 22, 2020 00:03 UTC
DO CUONG VDirector
GrantCommon Stock 1,600 $3.50 $5,600.00
Disclosure

SEC source: 0001771317-20-000003 · primary_doc.xml · nonDerivative · entry 1

Do Cuong V · CIK 0001477037 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 96,841

F1 · balance_after: On 11/21/2019 a reverse stock split was effected; total shares indicated are post-split.

F2 · ownership.nature: Shares are held in the name of Do & Rickles Investments LLC

Read SEC document
January 02, 2020 Filed Oct 22, 2020 00:18 UTC GrantCommon Stock 1,600 $3.50 $5,600.00
Disclosure

SEC source: 0001771317-20-000004 · primary_doc.xml · nonDerivative · entry 1

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,044

F1 · balance_after: On 11/21/2019 a reverse stock split was effected; total shares indicated are post-split.

Read SEC document
January 02, 2020 Filed Sep 29, 2021 10:56 UTC GrantCommon Stock 1,600 $0.00 $0.00
Disclosure

SEC source: 0001520138-21-000592 · ownership.xml · nonDerivative · entry 1

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,600

Read SEC document
January 02, 2020 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
GrantCommon Stock 1,600 $0.00 $0.00
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · nonDerivative · entry 6

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,258,956

F4 · shares: The Issuer granted 1,600 shares of common stock to the reporting person as compensation for his service on the Issuer's board of directors.

Read SEC document
January 02, 2020 Filed Aug 26, 2022 17:10 UTC
PEIZER TERREN SDirector · 10% owner
GrantCommon Stock 4,422 Not disclosed Not disclosed
Disclosure

SEC source: 0001520138-22-000381 · ownership.xml · nonDerivative · entry 5

PEIZER TERREN S · CIK 0000904534 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,257,356

F7 · price: The Issuer paid $13,487 of accrued interest on the Debenture through the issuance of 4,422 shares of the Issuer's common stock to Acuitas.

F3 · ownership.nature: Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Read SEC document
October 13, 2019 Filed Oct 21, 2020 20:26 UTC Grantoptions · Derivative 800 $7.50 Strike: $7.50 $6,000.00
Disclosure

SEC source: 0001771317-20-000005 · primary_doc.xml · derivative · entry 2

Sherman Michael Edward · CIK 0001730468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,006

Underlying: common stock · 800 shares

Expires 2024-10-13

F2 · balance_after: On 11/21/2019 a reverse stock split was effected; derivative securities are post-split calculations.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.